Diagnostic News and Research

RSS
IVAX Diagnostics net revenues decrease 0.4% to $4,375,000 for quarter ended June 30, 2011

IVAX Diagnostics net revenues decrease 0.4% to $4,375,000 for quarter ended June 30, 2011

Quanterix's ELISA precisely measures low abundance cytokines in Crohn's disease

Quanterix's ELISA precisely measures low abundance cytokines in Crohn's disease

St. Joseph's Women's Hospital inaugurates new 64-suite neonatal intensive care unit

St. Joseph's Women's Hospital inaugurates new 64-suite neonatal intensive care unit

Wistar Institute, Graham Cancer Center enter research collaboration

Wistar Institute, Graham Cancer Center enter research collaboration

New quick malaria diagnostic test may help reduce overtreatment

New quick malaria diagnostic test may help reduce overtreatment

DiaGenic reports operating revenue of NOK 1,151 thousand for second quarter 2011

DiaGenic reports operating revenue of NOK 1,151 thousand for second quarter 2011

State roundup: Opposition to Calif. health insurance regulation bill

State roundup: Opposition to Calif. health insurance regulation bill

Gene Security Network announces commercial launch of non-invasive prenatal test

Gene Security Network announces commercial launch of non-invasive prenatal test

Optical coherence tomography can distinguish between high and low risk pancreatic cysts

Optical coherence tomography can distinguish between high and low risk pancreatic cysts

FDA approves Zelboraf (vemurafenib) for advanced skin cancer

FDA approves Zelboraf (vemurafenib) for advanced skin cancer

Neoprobe sells gamma detection device business to Devicor

Neoprobe sells gamma detection device business to Devicor

Roche receives FDA approval for Zelboraf to treat BRAF mutation-positive metastatic melanoma

Roche receives FDA approval for Zelboraf to treat BRAF mutation-positive metastatic melanoma

Zelboraf receives FDA approval for treatment of metastatic melanoma

Zelboraf receives FDA approval for treatment of metastatic melanoma

Health Canada grants medical device license to Gen-Probe's PROGENSA PCA3 assay

Health Canada grants medical device license to Gen-Probe's PROGENSA PCA3 assay

PERCH study to look at current and likely future causes of childhood pneumonia

PERCH study to look at current and likely future causes of childhood pneumonia

Methodist, Philips partner to develop new imaging technology for infectious diseases

Methodist, Philips partner to develop new imaging technology for infectious diseases

Study investigates autism spectrum disorder, sibling recurrence

Study investigates autism spectrum disorder, sibling recurrence

Concord Medical second quarter total net revenues increase 24.5% to $19.2 million

Concord Medical second quarter total net revenues increase 24.5% to $19.2 million

China Medical first fiscal quarter net revenues increase 27.4% to US$36.7 million

China Medical first fiscal quarter net revenues increase 27.4% to US$36.7 million

New insights into causes of rheumatoid arthritis

New insights into causes of rheumatoid arthritis

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.